Skip to main content

Published locations for Ibrutinib-rituximab ‘new standard of care’ in younger CLL patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib-rituximab ‘new standard of care’ in younger CLL patients

User login

  • Reset your password
  • /content/ibrutinib-rituximab-new-standard-care-younger-cll-patients
  • /hematologynews/article/190863/cll/ibrutinib-rituximab-new-standard-care-younger-cll-patients
  • /oncologypractice/article/190863/cll/ibrutinib-rituximab-new-standard-care-younger-cll-patients
  • /hematologynews/nhlhub/article/190863/cll/ibrutinib-rituximab-new-standard-care-younger-cll-patients
  • /hematology-oncology/article/190863/cll/ibrutinib-rituximab-new-standard-care-younger-cll-patients
  • /b-cell-lymphoma-icymi/article/190863/cll/ibrutinib-rituximab-new-standard-care-younger-cll-patients